AMNEAL PHARMACEUTICALS, INC. (AMRX)
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
LanzaTech JV Successful IPO Underscores Strategic Value of More Secure Fuel Supply
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Nordson Corporation Declares Third Quarter Dividend for Fiscal Year 2026
Mobix Labs to Acquire U.S.-Built Drone Manufacturer Vision Aerial, Expanding Into Global Drone and Aerial Intelligence Markets
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
FICO Score 10T Now Integrated Into Optimal Blues Capital Markets Platform